Method and apparatus for performance of thermal bronchioplasty to reduce covid-19-induced respiratory distress and treat covid-19-damaged distal lung regions
Apparatus and methods for deactivating pulmonary nerves extending along the main bronchi of a mammalian subject to reduce ARDS effects by advancing an ultrasound transducer into the right and subsequently left main bronchus. The ultrasound transducer emits circumferential ultrasound so as to heat a circumferential tissue volume encompassing the right and left main bronchus. The energy of <10 W acoustic for <5 sec will not be sufficient to cause tissue necrosis but sufficient to inactivate nerve conduction. This treatment can be performed without locating or focusing on individual pulmonary nerves.
1. A COVID-19 treatment method comprising:
diagnosing a patient as having at least one COVID-19 damaged distal lung region;
upon the diagnosing of the patient as having the at least one COVID-19 damaged distal lung region, inserting a distal end portion of an ultrasound catheter into a bronchial tree of the patient so that said distal end portion is disposed in a distal portion of the bronchial tree proximate the at least one COVID-19 damaged distal lung region;
inflating a compliant balloon at a distal end of the ultrasound catheter with a cooling and coupling liquid so that the balloon enters into effective ultrasound-transmitting contact with a bronchial wall of the patient proximate the at least one COVID-19 damaged distal lung region; and
thereafter energizing an ultrasonic transducer at the distal end of said ultrasound catheter to apply circumferential focused or unfocused ultrasound energy to the at least one COVID-19 damaged distal lung region of the patient via the bronchial wall, in pulses of predetermined duration and predetermined inter-pulse spacing effective to induce mechanical stress in alveoli and lung epithelial layers in the at least one COVID-19 damaged distal lung region.
2. A COVID-19 treatment method comprising:
diagnosing a subject as having at least one COVID-19 damaged distal lung region;
upon the diagnosing of the subject as having the at least one COVID-19 damaged distal lung region, inserting a distal portion of an elongate introducer instrument into a bronchial tree of the subject;
advancing an ultrasound catheter through a working channel of said elongate introducer instrument;
disposing a distal end portion of said ultrasound catheter in a distal portion of the bronchial tree proximate the at least one COVID-19 damaged distal lung region;
inflating a compliant balloon at a distal end of the ultrasound catheter with a cooling and coupling liquid so that the balloon enters into contact with a bronchial wall of the subject proximate the at least one COVID-19 damaged distal lung region;
operating a contact detector to determine whether circumferential contact of the balloon with the bronchial wall of the subject is achieved; and
thereafter energizing an ultrasonic transducer at the distal end of said ultrasound catheter to apply circumferential focused or unfocused ultrasound energy to the at least one COVID-19 damaged distal lung region in pulses of predetermined duration and predetermined inter-pulse spacing effective to induce mechanical stress in alveoli and lung epithelial layers in the at least one COVID-19 damaged distal lung region.
3. The method of claim 2 wherein said ultrasound catheter is steerable, the advancing of said ultrasound catheter including introducing said ultrasound catheter through said elongate introducer instrument, wherein an optical fiber is inserted in a central lumen of the ultrasound catheter for guidance.
4. The method of claim 2 wherein the ultrasound catheter is provided with depth markings, further comprising:
imaging a treatment site prior to the inserting of said distal portion of the elongate introducer instrument; and
determining a length of insertion of the ultrasound catheter in accordance with images of the treatment site,
the advancing of said ultrasound catheter being terminated upon attainment of the determined length of insertion of the ultrasound catheter.
5. The method of claim 2 wherein the elongate introducer instrument is a steerable sheath containing an optical imaging fiber for visualization, the advancing of the ultrasound catheter including:
first inserting into the subject the steerable sheath containing the optical imaging fiber for visualization;
positioning a distal tip of the steerable sheath distal to the main bronchial bifurcation of the subject; and
replacing the optical imaging fiber with the ultrasound catheter.
6. The method of claim 2 , further comprising using the elongate introducer instrument to place a guidewire, the advancing of the ultrasound catheter including advancing the ultrasound catheter over the guidewire after the elongate introducer instrument has been withdrawn.
7. The method of claim 2 , further comprising operating the ultrasonic transducer in a receive mode to detect and prevent improper coupling of the balloon and the bronchial wall.
8. The method of claim 2 , further comprising operating the ultrasonic transducer in a receive mode and detecting distance of an esophagus from the balloon to avoid esophageal injury in case of the esophagus containing air.